Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split

Haoxi Health Technology (NASDAQ: HAO) will implement a 1‑for‑20 reverse share split of its Class A and Class B ordinary shares, effective for trading on a split-adjusted basis on August 14, 2026 on Nasdaq.

Rhea-AI Summary

Haoxi Health Technology (NASDAQ: HAO) will implement a 1‑for‑20 reverse share split of its Class A and Class B ordinary shares, effective for trading on a split-adjusted basis on August 14, 2026 on Nasdaq.

After the split, the par value per share will change from $0.0000001 to $0.000002. Issued and outstanding Class A shares will decline from 11,904,632 to approximately 595,232, and Class B shares from 317,897 to approximately 15,895, subject to rounding of fractional shares, which will be rounded up to the nearest whole share. The Class A shares will continue to trade under the symbol “HAO” with new CUSIP G4290F134. Transhare Corporation LLC will act as exchange and paying agent, and most shareholders will not need to take action.

Positive

• Fractional share interests will be rounded up to the nearest whole share
• Outstanding Class A shares reduced to approximately 595,232 after 1‑for‑20 split
• Outstanding Class B shares reduced to approximately 15,895 after 1‑for‑20 split
• Class A shares remain listed on Nasdaq under symbol HAO post-split

Negative

• None.

News Explained

The split changes share-count and per-share-price mechanics without changing company value itself, while the actual trading price remains uncertain.

The reverse split reduces the share count and raises the per-share price proportionally; the split itself does not change Haoxi Health Technology’s company value.

Haoxi expects the Class A shares to trade at approximately 20 times their pre-split price, but cautions that the actual post-split price may differ, may not be maintained, and may not remain above the pre-split price.

Argus Aug 12 session 14 alerts

-4.85% close to close 4.7x rel. volume Open Argus

Details

Market move: HAO -4.85% in the Aug 12 session. 1-for-20 reverse split

-25.7% Trough in 3 hr 21 min

$1.09M Market Cap

On Aug 12, the day this news came out, HAO closed 4.85% below the previous close. Argus tracked a trough of -25.7% from its starting point during tracking. Our momentum scanner recorded 14 alerts for this stock that day. Relative volume reached 4.7x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 12 session.

Key Figures

Reverse split ratio: 1-for-20 Adjusted trading date: August 14, 2026 Expected price multiple: approximately 20 times +4 more

Reverse split ratio

1-for-20

Class A and Class B ordinary shares

Adjusted trading date

August 14, 2026

Nasdaq Capital Market opening

Expected price multiple

approximately 20 times

Compared with the pre-split trading price

New par value

$0.000002 per share

Following the reverse split

Class A shares outstanding

11,904,632 to approximately 595,232

Following the reverse split

Class B shares outstanding

317,897 to approximately 15,895

Following the reverse split

Board approval date

July 23, 2026

Reverse split approval

Previous Stock split Reports

2 past events · Latest: May 19

Same Type 2 events

1. May 19

   Reverse split

   24h Move

   -21.4%

   Comparable reverse split; Nasdaq trading began on May 21, 2026.

2. Jan 23

   Reverse split

   24h Move

   -22.4%

   Comparable reverse split; trading became effective January 27, 2025.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse share split, par value, cusip number

3 terms

reverse share split financial

"announced that it will effect a reverse share split of its outstanding Class A ordinary shares"

A reverse share split is when a company reduces the number of its shares outstanding by combining multiple shares into one, effectively increasing the price of each share. For investors, this can help improve the company's image or meet stock exchange listing requirements, but it does not change the total value of their investment. It’s similar to turning many small pieces of a puzzle into fewer larger pieces—nothing new is added or lost, just rearranged.

par value financial

"par value of $0.0000001 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

cusip number regulatory

"with the new CUSIP number, G4290F134"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEIJING, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; "we" or the "Company"), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0000001 per share (the "Class A Ordinary Shares") and Class B ordinary shares, par value $0.0000001 per share (the "Class B Ordinary Shares"), at a ratio of 1-for-20.

Our Class A Ordinary Shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market ("Nasdaq") on August 14, 2026. Following the reverse share split, the Class A Ordinary Shares and Class B Ordinary Shares will have a new par value of $0.000002 per share and the Class A Ordinary Shares will continue to trade on Nasdaq under the symbol "HAO" with the new CUSIP number, G4290F134. The reverse share split is expected to lead the Company’s Class A Ordinary Shares to trade at approximately 20 times the price per share at which it trades prior to the effectiveness of the reverse share split. The Company, however, cannot assure that the price of its Class A Ordinary Shares after the reverse split will reflect the 1-for-20 reverse split ratio, that the price per share following the effective time of the reverse split will be maintained for any period of time, or that the price will remain above the pre-split trading price.

No fractional shares will be issued in connection with the reverse share split and all such fractional interests will be rounded up to the nearest whole number of Class A Ordinary Shares and Class B Ordinary Shares.

The reverse share split will reduce the number of issued and outstanding Class A Ordinary Shares from 11,904,632 to approximately 595,232, and the number of issued and outstanding Class B Ordinary Shares from 317,897 to approximately 15,895, subject to any adjustments resulting from the treatment of the fractional shares.

On July 23, 2026, the board of directors of the Company approved the reverse share split of the Class A Ordinary Shares and Class B Ordinary Shares, at a ratio of 1-for-20.

Transhare Corporation LLC is acting as the exchange agent and paying agent for the reverse share split. Shareholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse share split.

Transhare Corporation LLC will provide instructions to any shareholders with certificates regarding the process in connection with the exchange of pre-reverse share split share certificates for ownership in book-entry form or share certificates on a post-reverse share split basis. Shareholders are encouraged to contact their bank, broker or custodian with any procedural questions.

About Haoxi Health Technology Limited

Haoxi Health Technology Limited is a Beijing-headquartered online marketing solution provider specializing in serving healthcare industry advertiser clients. The Company offers one-stop online marketing solutions, particularly in online short video marketing, helping advertisers acquire and retain customers on popular Chinese platforms. For more information, visit: http://ir.haoximedia.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; the Company's future acquisition opportunities; the Company's ability to identify any acquisition opportunities that fit with our business strategies; the Company's ability to consummate an attractive acquisition and realize the benefits of such transaction; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For investor and media inquiries, please contact:

Haoxi Health Technology Ltd
Investor Relations
ir@haoximedia.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the ratio of Haoxi Health Technology (NASDAQ: HAO) reverse share split in August 2026?

Haoxi Health Technology is implementing a 1-for-20 reverse share split of its Class A and Class B ordinary shares. According to Haoxi Health Technology, every 20 existing shares will be consolidated into one share, with no fractional shares issued.

When will Haoxi Health Technology’s 1-for-20 reverse share split take effect on Nasdaq?

The reverse share split will be effective for trading on a split-adjusted basis on August 14, 2026. According to Haoxi Health Technology, Class A shares will continue trading on the Nasdaq Capital Market under symbol HAO with a new CUSIP number.

How will the Haoxi Health Technology (HAO) reverse split affect the number of outstanding shares?

The reverse split will reduce Class A shares from 11,904,632 to approximately 595,232 and Class B shares from 317,897 to approximately 15,895. According to Haoxi Health Technology, figures may adjust slightly due to fractional share rounding.

Will Haoxi Health Technology (HAO) issue fractional shares in the 1-for-20 reverse split?

Haoxi Health Technology will not issue fractional shares in the reverse split. According to Haoxi Health Technology, any fractional interests in Class A or Class B shares will be rounded up to the nearest whole share for shareholders.

Do Haoxi Health Technology (NASDAQ: HAO) shareholders need to take action for the reverse share split?

Shareholders holding HAO shares in book-entry or brokerage accounts generally do not need to take action. According to Haoxi Health Technology, Transhare Corporation LLC will instruct certificated shareholders on exchanging pre-split certificates for post-split ownership records.

How might Haoxi Health Technology’s 1-for-20 reverse split impact its share price?

The reverse split is expected to make the Class A share price trade at about 20 times its pre-split level. According to Haoxi Health Technology, there is no assurance the post-split price will match, maintain, or exceed that implied ratio.